// App-Quantinova.ai

1974 : The Rat Homolog to FX201, a Gene Therapy in Development for the Treatment of Osteoarthritis, Demonstrates Dose-Dependent Decreases in the Severity of Cartilage and Bone Lesions Following Anterior Cruciate Ligament Transection

Researchers

Presenter

  • Rebecca Senter

Principal Investigators

  • Monika Chabicovksy

  • Emily Walsh Martin

  • Genevieve Langevin-Carpentier

  • Neil Bodick

Medical Centers

  • Flexion Therapeutics, Burlington

  • Beechy Ridge ToxPath LLC, Clay

  • MC Toxicology Consulting, Vienna, Austria

  • Charles River Laboratories, Senneville, Canada

Locations

  • Austria

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoarthritis

Biomarkers

  • N/A

Drug/Treatment

  • Isoflurane

  • FX-201

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved